

Can't fill your Arformoterol (Brovana) prescription? Here are real COPD medication alternatives your doctor may consider, including other nebulizer options.
If you depend on Arformoterol to keep your COPD symptoms under control and suddenly can't fill your prescription, it's understandably stressful. Missing doses of a long-acting bronchodilator can lead to increased breathlessness, reduced activity tolerance, and even COPD flare-ups.
But you're not stuck. There are several effective alternatives to Arformoterol that your doctor can prescribe — some that work through a nebulizer just like Arformoterol, and others that use different delivery methods. Let's walk through your options.
Arformoterol (brand name Brovana) is a long-acting beta-2 adrenergic agonist (LABA). It works by relaxing the muscles around your airways, opening them up so you can breathe more easily. The effect lasts approximately 12 hours, which is why it's taken twice daily.
What makes Arformoterol unique is its delivery method: it comes as an inhalation solution that you breathe in through a nebulizer. This is especially helpful for patients who have trouble using handheld inhalers — including many older adults and people with severe COPD or arthritis.
Arformoterol is specifically the active (R,R)-enantiomer of Formoterol, designed to deliver more targeted bronchodilation. For a complete explanation of the science, see our article on how Arformoterol works.
There are several reasons you might need to switch from Arformoterol:
Perforomist (Formoterol Fumarate Inhalation Solution) is the closest alternative to Arformoterol because it's also a nebulized LABA. In fact, Arformoterol is the purified active enantiomer of Formoterol, so these two medications are closely related.
Key facts about Perforomist:
If your main reason for being on Arformoterol is the nebulizer delivery, Perforomist is likely your doctor's first choice as a substitute.
Serevent Diskus (Salmeterol Xinafoate) is another long-acting beta-2 agonist, but it comes as a dry powder inhaler (DPI) rather than a nebulizer solution.
Key facts about Serevent Diskus:
Salmeterol is widely available and often less expensive than nebulized LABAs. Generic versions are available, making it a cost-effective option.
Striverdi Respimat (Olodaterol) is a newer once-daily LABA that uses a soft mist inhaler. The soft mist technology creates a slow-moving aerosol that's easier to inhale than a traditional metered-dose inhaler.
Key facts about Striverdi Respimat:
Olodaterol is also available in combination with Tiotropium (a long-acting muscarinic antagonist) as Stiolto Respimat, which can provide dual bronchodilation in a single inhaler.
Arcapta Neohaler (Indacaterol Maleate) is another once-daily LABA option delivered via dry powder inhaler.
Key facts about Arcapta Neohaler:
The best alternative depends on your specific situation:
Important: Never switch COPD medications on your own. Always talk to your doctor or pulmonologist before making any changes. They can evaluate your lung function, inhaler technique, and insurance coverage to find the best fit. Need help finding a prescriber? See our guide on how to find a doctor who can prescribe Arformoterol.
Not being able to fill your Arformoterol prescription is frustrating, but it doesn't mean you have to go without effective COPD treatment. From nebulized Formoterol (Perforomist) to once-daily inhaler options like Olodaterol and Indacaterol, there are real alternatives that can keep your airways open and your symptoms managed.
Before switching, try using Medfinder to see if Arformoterol is available at a pharmacy near you. If it's truly unavailable, your doctor can help you find the right substitute for your needs.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.